Canaccord Genuity


Canaccord Genuity Maintains Hold On Xylem Shares, $36 PT

In a research report issued today, Canaccord Genuity analyst John Quealy maintained a Hold rating on Xylem (NYSE:XYL) with a price target of …

Canaccord Genuity Maintains Buy On Stryker Shares, $84 PT

In a research report issued today, Canaccord Genuity analyst William Plovanic maintained a Buy rating on Stryker Corp (NYSE:SYK) with a price target …

Canaccord Genuity Reiterates Buy On Zulily Shares, $45 PT

In a research report issued today, Canaccord Genuity analyst Michael Graham reiterated a Buy rating on Zulily Inc (NASDAQ:ZU) with a price target …

Canaccord Genuity Assigns Buy On Urban Outfitters Shares, $47 PT

In a research report issued yesterday, Canaccord Genuity analyst Laura Champine assigned a Buy rating on Urban Outfitters (NASDAQ:URBN) with a price target …

Canaccord Genuity Reiterates Hold On Pentair Shares, $67 PT

In a research report issued today, Canaccord Genuity analyst John Quealy reiterated a Hold rating on Pentair (NYSE:PNR) with a price target of …

Canaccord Genuity Assigns Buy On Steven Madden Shares, $41 PT

In a research report issued yesterday, Canaccord Genuity analyst Camilo Lyon assigned a Buy rating on Steven Madden (NASDAQ:SHOO) with a price target …

Canaccord Genuity Reiterates Buy On Pandora Media Shares, $43 PT

In a research report issued today, Canaccord Genuity analyst Michael Graham reiterated a Buy rating on Pandora Media Inc (NYSE:P) with a price …

Canaccord Genuity Assigns Buy On Novadaq Technologies Shares, $18 PT

In a research report issued today, Canaccord Genuity analyst Jason Mills assigned a Buy rating on Novadaq Technologies (NASDAQ:NVDQ) with a price target of …

Canaccord Genuity Maintains Buy On Herbalife Shares, $73 PT

In a research report issued today, Canaccord Genuity analyst Scott Van Winkle maintained a Buy rating on Herbalife Ltd (NYSE:HLF) with a price …

Canaccord Genuity Maintains Hold On Medifast, $29 PT

In a research report issued today, Canaccord Genuity analyst Scott Van Winkle maintained a Hold rating on Medifast (NYSE:MED) with a price target …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts